CD44-Mediated Methotrexate Delivery by Hyaluronan-Coated Nanoparticles Composed of a Branched Cell-Penetrating Peptide

Jisang Yoo; N. Sanoj Rejinold; Dae Yong Lee; Ilkoo Noh; Won Gun Koh; Sangyong Jon; Yeu Chun Kim

doi:10.1021/acsbiomaterials.9b01724

CD44-Mediated Methotrexate Delivery by Hyaluronan-Coated Nanoparticles Composed of a Branched Cell-Penetrating Peptide

Jisang Yoo, N. Sanoj Rejinold, Dae Yong Lee, Ilkoo Noh, Won Gun Koh, Sangyong Jon, Yeu Chun Kim

Department of Chemical and Biomolecular Engineering

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

Branched polymers as drug delivery carriers have been widely attempted due to their outstanding drug loading capability and complex stability like branched polyethyleneimine (B-PEI). However, branched polymers without biodegradability may cause toxicity as they can accumulate in the body. Herein, we report branched modified nona-arginine (B-mR9) composed of redox-cleavable disulfide bonds to form stable complexes with methotrexate (MTX) as an anticancer agent, which is further coated with hyaluronic acid (HA). The HA-coated nanoparticles provide targetability for the CD44 cell surface receptor. The B-mR9-MTX/HA can effectively aid in intracellular MTX delivery to CD44 overexpressing cancer cells being degradable by the reducing environments of the cancer cells. The B-mR9-MTX/HA exhibits not only a glutathione-triggered degradability but also an outstanding CD44-mediated MTX delivery efficacy. In addition, its superior tumor inhibition capability was confirmed through an in vivo study. The results suggest that the HA-coated B-mR9 nanoparticle can be used as a drug delivery platform.

Original language	English
Pages (from-to)	494-504
Number of pages	11
Journal	ACS Biomaterials Science and Engineering
Volume	6
Issue number	1
DOIs	https://doi.org/10.1021/acsbiomaterials.9b01724
Publication status	Published - 2020 Jan 13

Bibliographical note

Funding Information:
J.Y. and N.S.R. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. This work was supported by grants from the National Research Foundation of Korea (NRF-2019R1A4A1024116, NRF-2019R1A2C2085962, and NRF-2018M3A9E2024583). The authors declare no competing financial interest.

Publisher Copyright:
© 2019 American Chemical Society.

All Science Journal Classification (ASJC) codes

Biomaterials
Biomedical Engineering

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/acsbiomaterials.9b01724

Cite this

@article{9038125ac54c4d4f8d4124961b0ff62e,

title = "CD44-Mediated Methotrexate Delivery by Hyaluronan-Coated Nanoparticles Composed of a Branched Cell-Penetrating Peptide",

abstract = "Branched polymers as drug delivery carriers have been widely attempted due to their outstanding drug loading capability and complex stability like branched polyethyleneimine (B-PEI). However, branched polymers without biodegradability may cause toxicity as they can accumulate in the body. Herein, we report branched modified nona-arginine (B-mR9) composed of redox-cleavable disulfide bonds to form stable complexes with methotrexate (MTX) as an anticancer agent, which is further coated with hyaluronic acid (HA). The HA-coated nanoparticles provide targetability for the CD44 cell surface receptor. The B-mR9-MTX/HA can effectively aid in intracellular MTX delivery to CD44 overexpressing cancer cells being degradable by the reducing environments of the cancer cells. The B-mR9-MTX/HA exhibits not only a glutathione-triggered degradability but also an outstanding CD44-mediated MTX delivery efficacy. In addition, its superior tumor inhibition capability was confirmed through an in vivo study. The results suggest that the HA-coated B-mR9 nanoparticle can be used as a drug delivery platform.",

author = "Jisang Yoo and Rejinold, {N. Sanoj} and Lee, {Dae Yong} and Ilkoo Noh and Koh, {Won Gun} and Sangyong Jon and Kim, {Yeu Chun}",

note = "Funding Information: J.Y. and N.S.R. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. This work was supported by grants from the National Research Foundation of Korea (NRF-2019R1A4A1024116, NRF-2019R1A2C2085962, and NRF-2018M3A9E2024583). The authors declare no competing financial interest. Publisher Copyright: {\textcopyright} 2019 American Chemical Society.",

year = "2020",

month = jan,

day = "13",

doi = "10.1021/acsbiomaterials.9b01724",

language = "English",

volume = "6",

pages = "494--504",

journal = "ACS Biomaterials Science and Engineering",

issn = "2373-9878",

publisher = "American Chemical Society",

number = "1",

}

TY - JOUR

T1 - CD44-Mediated Methotrexate Delivery by Hyaluronan-Coated Nanoparticles Composed of a Branched Cell-Penetrating Peptide

AU - Yoo, Jisang

AU - Rejinold, N. Sanoj

AU - Lee, Dae Yong

AU - Noh, Ilkoo

AU - Koh, Won Gun

AU - Jon, Sangyong

AU - Kim, Yeu Chun

N1 - Funding Information: J.Y. and N.S.R. contributed equally. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. This work was supported by grants from the National Research Foundation of Korea (NRF-2019R1A4A1024116, NRF-2019R1A2C2085962, and NRF-2018M3A9E2024583). The authors declare no competing financial interest. Publisher Copyright: © 2019 American Chemical Society.

PY - 2020/1/13

Y1 - 2020/1/13

N2 - Branched polymers as drug delivery carriers have been widely attempted due to their outstanding drug loading capability and complex stability like branched polyethyleneimine (B-PEI). However, branched polymers without biodegradability may cause toxicity as they can accumulate in the body. Herein, we report branched modified nona-arginine (B-mR9) composed of redox-cleavable disulfide bonds to form stable complexes with methotrexate (MTX) as an anticancer agent, which is further coated with hyaluronic acid (HA). The HA-coated nanoparticles provide targetability for the CD44 cell surface receptor. The B-mR9-MTX/HA can effectively aid in intracellular MTX delivery to CD44 overexpressing cancer cells being degradable by the reducing environments of the cancer cells. The B-mR9-MTX/HA exhibits not only a glutathione-triggered degradability but also an outstanding CD44-mediated MTX delivery efficacy. In addition, its superior tumor inhibition capability was confirmed through an in vivo study. The results suggest that the HA-coated B-mR9 nanoparticle can be used as a drug delivery platform.

AB - Branched polymers as drug delivery carriers have been widely attempted due to their outstanding drug loading capability and complex stability like branched polyethyleneimine (B-PEI). However, branched polymers without biodegradability may cause toxicity as they can accumulate in the body. Herein, we report branched modified nona-arginine (B-mR9) composed of redox-cleavable disulfide bonds to form stable complexes with methotrexate (MTX) as an anticancer agent, which is further coated with hyaluronic acid (HA). The HA-coated nanoparticles provide targetability for the CD44 cell surface receptor. The B-mR9-MTX/HA can effectively aid in intracellular MTX delivery to CD44 overexpressing cancer cells being degradable by the reducing environments of the cancer cells. The B-mR9-MTX/HA exhibits not only a glutathione-triggered degradability but also an outstanding CD44-mediated MTX delivery efficacy. In addition, its superior tumor inhibition capability was confirmed through an in vivo study. The results suggest that the HA-coated B-mR9 nanoparticle can be used as a drug delivery platform.

UR - http://www.scopus.com/inward/record.url?scp=85077642443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077642443&partnerID=8YFLogxK

U2 - 10.1021/acsbiomaterials.9b01724

DO - 10.1021/acsbiomaterials.9b01724

M3 - Article

C2 - 33463200

AN - SCOPUS:85077642443

SN - 2373-9878

VL - 6

SP - 494

EP - 504

JO - ACS Biomaterials Science and Engineering

JF - ACS Biomaterials Science and Engineering

IS - 1

ER -

CD44-Mediated Methotrexate Delivery by Hyaluronan-Coated Nanoparticles Composed of a Branched Cell-Penetrating Peptide

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this